Click on the subcategory below to find drug monographs for that particular area.
Vascular endothelial growth factor (VEGF) triggers the formation of myofibroblasts associated with scarring after glaucoma surgery through a particular signaling pathway.
Alcon announced the FDA approval of Simbrinza Suspension, a new beta-blocker-free, fixed-combination therapy for patients with glaucoma.
Adding carotenoids, omega-3 fatty acids, or both to an antioxidant formulation of vitamins and minerals previously shown to be effective in reducing the risk of progression to advanced age-related macular degeneration (AMD) does not further lower the risk.
Make prescribing decisions with our charts and treatment algorithms.
